Holder snapshot 7 signals
Share change
+7,778,863
Put/Call ratio
92%
SEC-reported price per share
$39.24
Number of holders
81
Value change
+$310,281,997
Number of buys
65
Open additional details 1 more signal available
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
19,341,293

Security key

21833P301

Report period

Q1 2024

Institutions

81

Top holders

10

Ownership snapshot

Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rachael Louise Brake
Disclosed value leader
Rachael Louise Brake
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $6,958,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Rachael Louise Brake has the largest disclosed position value at $6.96M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rachael Louise Brake's linked filing trail.
Disclosed position value Top 5
Rachael Louise Brake $6.96M
Craig Stuart Millian $4.65M
Ikarian Capital, LLC $1.18M
VANGUARD GROUP INC $1.08M
Sio Capital Management, LLC $906K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rachael Louise Brake
3/4/5
Chief Scientific Officer
—
denominator unverified
$6,958,000
1,400,000 shares
— 13 Feb 2023
Craig Stuart Millian
3/4/5
Chief Operating Officer
—
denominator unverified
$4,645,186
934,645 shares
— 13 Feb 2023
Ikarian Capital, LLC
13F
Company
13F
—
denominator unverified
$1,183,230
195,899 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,083,914
179,456 shares
— 31 Dec 2023
Sio Capital Management, LLC
13F
Company
13F
—
denominator unverified
$906,000
150,000 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$489,633
81,065 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
81
Shares
8,529,313
Rows available
81
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
81
Q1 2024 holders
81
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .